Seite - (000128) - in Biomedical Chemistry: Current Trends and Developments

Fretland, A., Monshouwer, M. (2010) Enzyme Induction: Translating Multiple Approaches, Assays, Endpoints, and Opinions into a Valuable Induction Screening Strategy. Combinatorial Chemistry & High Throughput Screening, 13(2), 135-144. Fung, E.N., Chen, Y.H., Lau, Y.Y., (2003) Semi-automatic high-throughput determination of plasma protein binding using a 96-well plate filtrate assembly and fast liquid chromatography–tandem mass spectrometry. Journal of Chromatography B, 795(2), 187-194. Gallo, J.M. (2010) Pharmacokinetic/Pharmacodynamic-Driven Drug Development. Mount Sinai Journal of Medicine, 77(4), 381-388. Gong, J., Gan, J., Caceres-Cortes, J., Christopher, L.J., Arora, V., Masson, E., Williams, D., Pursley, J., Allentoff, A., Lago, M., Tran, S.B., Iyer, R.A., (2011) Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans. Drug Metabolism and Disposition, 39(5), 891-903. Guillarme, D., Veuthey, J.L. (2013) State-of-the art of (UHP)LC–MS(–MS) techniques and their practical application. Journal of Chromatography A, 1291, 1. Guilpin, R.K., Zhou, W. (2008) Ultrahigh-Pressure Liquid Chromatography: Fundamental Aspects of Compression and Decompression Heating. Journal of Chromatographic Science, 46(3), 248-253. Gupta, D., Varghese Gupta, S., Dahan, A., Tsume, Y., Hilfinger, J., Lee, K.D., Amidon, G.L., (2013) Increasing Oral Absorption of Polar Neuraminidase Inhibitors: A Prodrug Transporter Approach Applied to Oseltamivir Analogue. Molecular Pharmaceutics, 10(2), 512-522. ICH (1997), General considerations for clinical trials E8. ICH (2005) International Conference on Harmonisation, Validation of Analytical Procedures: Text and Methodology Q2 (R1). Conference on Harmonization. Keserü, G.M., Makara, G.M. (2009) The influence of lead discovery strategies on the properties of drug candidates. Natural Reviews and Drug Discovery, 8(3), 203-212. Kim, E., Kim, H., Suh, K., Kwon, S., Lee, G., Park, N.H., Hong, J., (2013) Metabolite identification of a new tyrosine kinase inhibitor, HM781-36B, and a pharmacokinetic study by liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry, 27(11), 1183-1195. Kozakai, K., Yamada, Y., Oshikata, M., Kawase, T., Suzuki, E., Haramaki, Y., Taniguchi, H., (2012) Reliable high-throughput method for inhibition assay of 8 cytochrome P450 isoforms using cocktail of probe substrates and stable isotope-labeled internal standards. Drug Metabolism and Pharmacokinetics, 27(5), 520-529. Kuentz, M., Nick, S., Parrott, N., Röthlisberger, D., (2006) A strategy for preclinical formulation development using GastroPlusTM as pharmacokinetic simulation tool and a statistical screening design applied to a dog study. European Journal of Pharmaceutical Sciences, 27(1), 91-99. Kundlik, M.L., Zaware, B.H., Kuchekar, S.R., (2012) Rapid and Specific Approach for Direct Measurement of Glimepiride in Human Plasma by LC–ESI-MS–MS Employing Automated 96 Well Format: Application to a Bioequivalence Study. Journal of Chromatographic Science, 50(1), 64-70. Lal, R., Sukbuntherng, J., Luo, W., Chen, D., Vu, A., Tovera, J., Cundy, K.C., (2009) Pharmacokinetics and Tolerability of Single Escalating Doses of Gabapentin Enacarbil: A Randomized-Sequence, Double-Blind, Placebo-Controlled Crossover Study in Healthy Volunteers. Clinical Therapeutics, 31(8), 1776-1786.